Warning letter
Age Management Institute Santa Barbara: warning letter of Apr 18, 2022
FDA warning letter 625261 · Division of Pharmaceutical Quality Operations IV
Key facts
| Reference number | 625261 |
|---|---|
| Company | Age Management Institute Santa Barbara |
| Subject | Compounding Pharmacy/Adulterated Drug Products |
| Issue date | Apr 18, 2022 |
| Posted date | May 3, 2022 |
| Issuing office | Division of Pharmaceutical Quality Operations IV |
| Product type | Drugs |
| Inspection city | Santa Barbara |
| Inspection ZIP | 93103 |
| Inspection start date | Mar 22, 2021 |
| Letter on fda.gov | fda.gov |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: